NANJING PROBIO BIOTECH CO LTD
Overview
NANJING PROBIO BIOTECH CO LTD is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering ARG34GLP-1(9-37)(H1); BSAL; BSPQI; DNASE I; HOST CELL LINES CHOK1-GENS AND CHOKI-ADCC+, VECTORS; MRNA CAP 2'-O-METHYLTRANSFERASE.
Core services & business areas
API / Drug Master Files
NANJING PROBIO BIOTECH CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- UPROCHO™ FB MEDIUM COMBINATIONActive2025-09-25
- UPROCHO™ FB MEDIUM SYSTEMActive2024-10-04
- HOST CELL LINES CHOK1-GENS AND CHOKI-ADCC+, VECTORSActive2021-10-25
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to NANJING PROBIO BIOTECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this NANJING PROBIO BIOTECH CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.